Millennium Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of medicines for the treatment of cancer in the United States and internationally. It develops and markets VELCADE for injection, a cancer therapy for the treatment of patients with multiple myeloma and relapsed mantle cell lymphoma.

The company was founded in 1993 and is headquartered in Cambridge, Massachusetts with facilities in San Diego, San Francisco, Tsukuba, and Osaka.

As of May 13, 2008, Millennium Pharmaceuticals, Inc. operates as a subsidiary of Takeda Pharmaceutical Co. Ltd.

Recent Milestones
edit

Millennium Pharmaceuticals — submitted two supplemental new drug applications (NDAs) for Velcade, a cancer treatment, to the U.S. Food and Drug Administration (4/26/11)

Posted 4/26/11 at 9:28am via masshightech.com
Millennium Pharmaceuticals was acquired by Takeda Pharmaceutical for $8.69B. (2/1/08)

Posted 9/7/09 at 5:14pm via takeda.com
Millennium Pharmaceuticals added Deborah Dunsire as CEO.

Posted 9/7/09 at 2:20am
Millennium Pharmaceuticals added Marsha H. Fanucci as CFO.

Posted 9/7/09 at 2:20am